|Articles|October 1, 2017
- BioPharm International-10-01-2017
- Volume 30
- Issue 10
BioPharm International, October 2017 Issue (PDF)
Click the title above to open the BioPharm International October 2017 issue in an interactive PDF format.
Advertisement
Articles in this issue
over 8 years ago
Improved Materials Enhance Parenteral Packagingover 8 years ago
Pharma’s Role in Puerto Rico’s Futureover 8 years ago
Control Viral Contaminants with Effective Testingover 8 years ago
Formulation of Biologics for Non-Invasive Deliveryover 8 years ago
FDA User Fees Promote Manufacturing Readinessover 8 years ago
Up and Away, M&Aover 8 years ago
Making Decisions Based on Riskover 8 years ago
The Challenges of PAT in the Scale-Up of Biologics Productionover 8 years ago
Optimizing Protein Aggregate Analysis by SECover 8 years ago
Development of Purification for Challenging Fc-Fusion ProteinsNewsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Advertisement
Advertisement
Advertisement
Trending on BioPharm International
1
First-in-Human Study Validates Safety of Next-Generation mRNA–LNP Platform
2
How CDMO Alliances Can Provide End-to-End Service that Reduces Drug Development Time and Costs
3
FDA Clears PharmaResearch IND for Nano-Based Cancer Drug PRD-101
4
High-Dose Nusinersen Slows Neurodegeneration in SMA Patients, Study Shows
5
